These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15489832)

  • 21. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble CD40 ligand in acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; van den Brand MJ; Boersma E; Zeiher AM; Simoons ML;
    N Engl J Med; 2003 Mar; 348(12):1104-11. PubMed ID: 12646667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

  • 24. Clots kill: hematologic pharmacology for ST-segment elevation myocardial infarction.
    James SH
    Crit Care Nurse; 2012 Dec; 32(6):35-41. PubMed ID: 23203953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clopidogrel should be added to aspirin for at least 1 year after percutaneous coronary interventions (CREDO) while before them its loading dose can reach 600mg (ISAR-COOL)].
    Gratsianskiĭ NA
    Kardiologiia; 2003; 43(5):71-3. PubMed ID: 12942928
    [No Abstract]   [Full Text] [Related]  

  • 26. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.
    Palmerini T; Benedetto U; Bacchi-Reggiani L; Della Riva D; Biondi-Zoccai G; Feres F; Abizaid A; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Genereux P; Bhatt DL; Orlandi C; De Servi S; Petrou M; Rapezzi C; Stone GW
    Lancet; 2015 Jun; 385(9985):2371-82. PubMed ID: 25777667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug treatment following an infarction].
    Lasserre B; Périat M
    Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
    [No Abstract]   [Full Text] [Related]  

  • 31. Eptifibatide and tirofiban: new preparations. Limited benefit.
    Prescrire Int; 2000 Oct; 9(49):135-8. PubMed ID: 11603412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis of antiaggregant therapy trials. Proposal of an additional reading key].
    Blardi P; de Lalla A; Di Perri T
    Recenti Prog Med; 1998 Oct; 89(10):494-500. PubMed ID: 9842251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of randomized trials of triple versus dual antiplatelet therapy after stent-based percutaneous coronary intervention.
    Takagi H; Umemoto T
    Int J Cardiol; 2011 Jul; 150(2):228-30. PubMed ID: 21636146
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
    MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
    [No Abstract]   [Full Text] [Related]  

  • 35. A national survey of Canadian practice patterns of warfarin after anterior wall myocardial infarction in the current era of dual antiplatelet therapy.
    Schwalm JD; Ahmad M; Eikelboom JW; Natarajan MK
    Am J Cardiol; 2010 Jun; 105(12):1844. PubMed ID: 20538142
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased morning ADP-dependent platelet aggregation persists despite dual antiplatelet therapy in patients with first ST-segment elevation myocardial infarction: Preliminary report.
    Koziński M; Bielis L; Wiśniewska-Szmyt J; Sukiennik A; Grabczewska Z; Swiatkiewicz I; Ziołkowski M; Rość D; Kubica J
    Cardiol J; 2008; 15(6):530-6. PubMed ID: 19039757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical therapy of early post-infarct angina].
    Folli G; Guerrera G; Melina D; Capaldi L
    Minerva Cardioangiol; 1987 Dec; 35(12):673-82. PubMed ID: 3330772
    [No Abstract]   [Full Text] [Related]  

  • 38. Updates in antiplatelet agents used in cardiovascular diseases.
    Cheng JW
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.